Dae Hwa Pharm Co Ltd
KOSDAQ:067080
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Dae Hwa Pharm Co Ltd
KOSDAQ:067080
|
KR |
|
T
|
TCJ Asia PCL
SET:TCJ
|
TH |
|
FNB Bancorp Inc
OTC:FBIP
|
US |
|
H
|
Hana 26 Special Purpose Acquisition Co
KOSDAQ:446750
|
KR |
|
N
|
Norsk Solar AS
OSE:NSOL
|
NO |
|
C
|
Circuit Research Labs Inc
OTC:CRLI
|
US |
|
G
|
Globe Commercials Ltd
BSE:540266
|
IN |
|
Kutcho Copper Corp
OTC:KCCFF
|
CA |
|
Electric Power Development Co Ltd
TSE:9513
|
JP |
|
Cermetek Microelectronics Inc
OTC:CRMK
|
US |
|
Sonaecom SGPS SA
F:XOA1
|
PT |
|
Exchange Bank
OTC:EXSR
|
US |
|
H
|
Home Concept France SA
PAR:MLHCF
|
FR |
|
H
|
Hana Twenty-Nine Special Purpose Acquisition Co
KOSDAQ:454640
|
KR |
|
T
|
Transportation and Logistics Systems Inc
OTC:TLSS
|
US |
|
S
|
Sipsa SA
SGO:SIPSA
|
CL |
Bankruptcy Probability
Dae Hwa Pharm Co Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Dae Hwa Pharm Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
D
|
Dae Hwa Pharm Co Ltd
KOSDAQ:067080
|
187.5B KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.2T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
643.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
368B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
240.1B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
189.8B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
297.3B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Dae Hwa Pharm Co Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Dae Hwa Pharm Co Ltd has total debt of 71.3B KRW. This includes both short-term (64.1B KRW) and long-term (7.2B KRW) debt.
You can find a full breakdown on its Balance Sheet.